EXAGEN INC. IPO

Completed

EXAGEN INC. completed its initial public offering on NASDAQ on September 19, 2019, pricing at $14.00 a share.

Ticker	XGN
Exchange	NASDAQ
Status	Completed
Listing date	September 19, 2019
Offering price	$14.00
Shares offered	3,600,000
Total raised	$50M

The offering

EXAGEN INC. sold 3,600,000 shares at $14.00 each on NASDAQ. Multiplied out, that is $50.4 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $50 million total recorded for the deal.

Company coverage

EXAGEN INC. — quote, profile and latest news →

Other recent IPOs

First Breach, Inc. · August 12, 2026
Advasa Holdings, Inc. · August 11, 2026
Latigo Biotherapeutics, Inc. · August 4, 2026
BOA Acquisition Corp. II · August 3, 2026
Obsidian Therapeutics, Inc. · August 3, 2026
Attovia Therapeutics, Inc. · July 29, 2026
Game Your Game Inc. · July 27, 2026
Scribe Therapeutics, Inc. · July 21, 2026

Source: SEC EDGAR filings for EXAGEN INC.. This page is general information, not investment advice.